<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">35262033</PMID><DateRevised><Year>2024</Year><Month>04</Month><Day>07</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2667-0380</ISSN><JournalIssue CitedMedium="Internet"><Volume>2</Volume><Issue>1</Issue><PubDate><Year>2022</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Journal of clinical virology plus</Title><ISOAbbreviation>J Clin Virol Plus</ISOAbbreviation></Journal><ArticleTitle>The incidence of infectious diseases and viruses other than SARS-CoV-2 amongst hospitalised children in Oslo, Norway during the Covid-19 pandemic 2020-2021.</ArticleTitle><Pagination><StartPage>100060</StartPage><MedlinePgn>100060</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jcvp.2021.100060</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">Measures to reduce spread of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) during the Covid-19 pandemic 2020-2021 may impact other microbiological agents. We aimed to investigate the incidence of infectious diseases and the incidence of viruses other than SARS-CoV-2 amongst children at The Department of Paediatric and Adolescent Medicine, Oslo University Hospital, Norway during 2020-2021 compared to previous years.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">Data from April 1st 2020 - March 31st 2021 were compared to data from corresponding 12-months periods 2017-2020. ICD-10 infectious disease diagnoses were collected from the Hospital Diagnosis and Procedure Registry and results of virus PCR analyses of different specimens (mainly nasopharyngeal (NF) and faecal samples) were collected from the Laboratory System at the Department of Microbiology.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">The number of hospital contacts with acute bronchiolitis, viral pneumonia, gastroenteritis and viral central nervous system infections were reduced by 90% (<i>p</i>&lt;0.0001), 89% (<i>p</i>&lt;0.0001), 74% (<i>p</i>&lt;0.0001) and 78% (<i>p</i>&lt;0.01), respectively. Respiratory syncytial virus (RSV), influenza virus A and B and Human metapneumovirus (HMPV) were almost completely absent during the pandemic period. The proportions of rhinovirus positive NF samples were 31.7% vs. 34.9% (<i>p</i>&lt;0.05), but not significantly different for adenovirus. The proportions of positive faecal samples were 1% vs. 10% for adenovirus (<i>p</i>&lt;0.00001) and 3.3% vs. 12% for norovirus (<i>p</i>&lt;0.00001), but not significantly different for rotavirus. The proportions of enterovirus positive samples were 3.5% vs. 21.6% (<i>p</i>&lt;0.00001).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">The incidence of several paediatric infectious diseases mainly of viral aetiology declined significantly during the Covid-19 pandemic. Some common respiratory viruses were almost completely absent.</AbstractText><CopyrightInformation>© 2021 The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Knudsen</LastName><ForeName>Per Kristian</ForeName><Initials>PK</Initials><AffiliationInfo><Affiliation>Department of Paediatric and Adolescent Medicine, Oslo University Hospital, Oslo, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lind</LastName><ForeName>Andreas</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Microbiology, Oslo University Hospital, Oslo, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Klundby</LastName><ForeName>Ingvild</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Microbiology, Oslo University Hospital, Oslo, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dudman</LastName><ForeName>Susanne</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Microbiology, Oslo University Hospital, Oslo, Norway.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Clinical Medicine, University of Oslo, Oslo, Norway.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>12</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Clin Virol Plus</MedlineTA><NlmUniqueID>9918283581506676</NlmUniqueID><ISSNLinking>2667-0380</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Covid-19</Keyword><Keyword MajorTopicYN="N">Enterovirus</Keyword><Keyword MajorTopicYN="N">Epidemiology</Keyword><Keyword MajorTopicYN="N">Human metapneumovirus (HMPV)</Keyword><Keyword MajorTopicYN="N">Norovirus</Keyword><Keyword MajorTopicYN="N">Paediatric infectious diseases</Keyword><Keyword MajorTopicYN="N">Respiratory syncytial virus (RSV)</Keyword><Keyword MajorTopicYN="N">Rhinovirus, adenovirus</Keyword><Keyword MajorTopicYN="N">Rotavirus &lt;PE-FRONTEND&gt;</Keyword><Keyword MajorTopicYN="N">influenza virus</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>11</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>12</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>12</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>3</Month><Day>9</Day><Hour>8</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>3</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>3</Month><Day>10</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>12</Month><Day>22</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35262033</ArticleId><ArticleId IdType="pmc">PMC8692238</ArticleId><ArticleId IdType="doi">10.1016/j.jcvp.2021.100060</ArticleId><ArticleId IdType="pii">S2667-0380(21)00052-1</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Norwegian Institute of Public Health  . 2021. Daily Report and Statistics About Coronavirus and COVID-19.https://www.fhi.no/en/id/infectious-diseases/coronavirus/daily-reports/daily-reports-COVID19/ [October 24th 2021]. Available from:</Citation></Reference><Reference><Citation>Størdal K., Ruiz P.L.-.D., Greve-Isdahl M., Surén P., Knudsen P.K., Løvdal Gulseth H., et al. Risk factors for SARS-CoV-2 infection and hospitalisation in children and adolescents in Norway: a nationwide population-based study. medRxiv. 2021 2021.07.01.21259887.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8919132</ArticleId><ArticleId IdType="pubmed">35277409</ArticleId></ArticleIdList></Reference><Reference><Citation>Docherty A.B., Harrison E.M., Green C.A., Hardwick H.E., Pius R., Norman L., et al. Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study. BMJ. 2020;369:m1985.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7243036</ArticleId><ArticleId IdType="pubmed">32444460</ArticleId></ArticleIdList></Reference><Reference><Citation>Swann O.V., Holden K.A., Turtle L., Pollock L., Fairfield C.J., Drake T.M., et al. Clinical characteristics of children and young people admitted to hospital with covid-19 in United Kingdom: prospective multicentre observational cohort study. BMJ. 2020;370:m3249.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7488201</ArticleId><ArticleId IdType="pubmed">32960186</ArticleId></ArticleIdList></Reference><Reference><Citation>City of Oslo  . 2021. Statistics Bank City of Oslo.https://statistikkbanken.oslo.kommune.no/webview/ [cited 2019. Available from:</Citation></Reference><Reference><Citation>Van Brusselen D., De Troeyer K., Ter Haar E., Vander Auwera A., Poschet K., Van Nuijs S., et al. Bronchiolitis in COVID-19 times: a nearly absent disease? Eur. J. Pediatr. 2021;180(6):1969–1973.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7847293</ArticleId><ArticleId IdType="pubmed">33517482</ArticleId></ArticleIdList></Reference><Reference><Citation>Polcwiartek L.B., Polcwiartek C., Andersen M.P., Østergaard L., Broccia M.D., Gislason G.H., et al. Consequences of coronavirus disease-2019 (COVID-19) lockdown on infection-related hospitalizations among the pediatric population in Denmark. Eur. J. Pediatr. 2021;180(6):1955–1963.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7868522</ArticleId><ArticleId IdType="pubmed">33555426</ArticleId></ArticleIdList></Reference><Reference><Citation>Nickbakhsh S., Mair C., Matthews L., Reeve R., Johnson P.C.D., Thorburn F., et al. Virus-virus interactions impact the population dynamics of influenza and the common cold. Proc. Natl. Acad. Sci. U S A. 2019;116(52):27142–27150.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6936719</ArticleId><ArticleId IdType="pubmed">31843887</ArticleId></ArticleIdList></Reference><Reference><Citation>Kampf G. Efficacy of ethanol against viruses in hand disinfection. J. Hosp. Infect. 2018;98(4):331–338.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7132458</ArticleId><ArticleId IdType="pubmed">28882643</ArticleId></ArticleIdList></Reference><Reference><Citation>Leung N.H.L., Chu D.K.W., Shiu E.Y.C., Chan K.H., McDevitt J.J., Hau B.J.P., et al. Respiratory virus shedding in exhaled breath and efficacy of face masks. Nat. Med. 2020;26(5):676–680.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8238571</ArticleId><ArticleId IdType="pubmed">32371934</ArticleId></ArticleIdList></Reference><Reference><Citation>Poole S., Brendish N.J., Tanner A.R., Clark T.W. Physical distancing in schools for SARS-CoV-2 and the resurgence of rhinovirus. Lancet Respiratory Med. 2020;8(12):e92–ee3.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7581315</ArticleId><ArticleId IdType="pubmed">33289636</ArticleId></ArticleIdList></Reference><Reference><Citation>Bruun T., Salamanca B.V., Bekkevold T., Døllner H., Gibory M., Gilje A.M., et al. Impact of the rotavirus vaccination program in norway after four years with high coverage. Pediatr. Infect. Dis. J. 2021;40(4):368–374.</Citation><ArticleIdList><ArticleId IdType="pubmed">33399430</ArticleId></ArticleIdList></Reference><Reference><Citation>Foley D.A., Yeoh D.K., Minney-Smith C.A., Martin A.C., Mace A.O., Sikazwe C.T., et al. The interseasonal resurgence of respiratory syncytial virus in australian children following the reduction of coronavirus disease 2019-related public health measures. Clin. Infect. Dis. 2021</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7929151</ArticleId><ArticleId IdType="pubmed">33594407</ArticleId></ArticleIdList></Reference><Reference><Citation>Ujiie M., Tsuzuki S., Nakamoto T., Iwamoto N. Resurgence of respiratory syncytial virus infections during COVID-19 pandemic, Tokyo, Japan. Emerg. Infect. Dis. 2021;27(11):2969–2970.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8544984</ArticleId><ArticleId IdType="pubmed">34388086</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>